These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32513891)

  • 61. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
    Said R; Tsimberidou AM
    Cancer J; 2019; 25(4):282-286. PubMed ID: 31335392
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity.
    Seligson ND; Warner JL; Dalton WS; Martin D; Miller RS; Patt D; Kehl KL; Palchuk MB; Alterovitz G; Wiley LK; Huang M; Shen F; Wang Y; Nguyen KA; Wong AF; Meric-Bernstam F; Bernstam EV; Chen JL
    J Am Med Inform Assoc; 2020 Nov; 27(11):1808-1812. PubMed ID: 32885823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Precision medicine in oncology: what is it exactly and where are we?
    Le Tourneau C; Kamal M; Bièche I
    Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
    [No Abstract]   [Full Text] [Related]  

  • 68. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Applied Precision Cancer Medicine in Neuro-Oncology.
    Taghizadeh H; Müllauer L; Furtner J; Hainfellner JA; Marosi C; Preusser M; Prager GW
    Sci Rep; 2019 Dec; 9(1):20139. PubMed ID: 31882734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Precision Cardio-Oncology.
    Dreyfuss AD; Bravo PE; Koumenis C; Ky B
    J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.
    Lee RT; Yang P; Greenlee H; Bauer-Wu S; Balneaves LG; Zick S
    Integr Cancer Ther; 2015 Jan; 14(1):98-105. PubMed ID: 25505022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Addressing the Search Challenges of Precision Medicine with Information Retrieval Systems and Physician Readers.
    Hollis KF; Roberts K; Bedrick S; Hersh WR
    Stud Health Technol Inform; 2020 Jun; 270():813-817. PubMed ID: 32570495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
    Vos S; van Delden JJM; van Diest PJ; Bredenoord AL
    Trends Genet; 2017 Feb; 33(2):118-128. PubMed ID: 28017398
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Personalized medicine: selected web resources.
    Stimson NF
    Dialogues Clin Neurosci; 2009; 11(4):464-9. PubMed ID: 20135904
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
    Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP
    Oncotarget; 2016 Aug; 7(35):56491-56500. PubMed ID: 27447854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Precision medicine in oncology: Challenges, stakes and new paradigms].
    Cox S; Rousseau-Tsangaris M; Abou-Zeid N; Dalle S; Leurent P; Cutivet A; Le HH; Kotb S; Bogaert B; Gardette R; Baran Y; Holder JM; Lerner L; Blay JY; Cambrosio A; Tredan O; Denèfle P
    Bull Cancer; 2019 Feb; 106(2):97-104. PubMed ID: 30713005
    [No Abstract]   [Full Text] [Related]  

  • 77. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Precision oncology: neither a silver bullet nor a dream.
    Sánchez NS; Mills GB; Mills Shaw KR
    Pharmacogenomics; 2017 Nov; 18(16):1525-1539. PubMed ID: 29061079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toward Precision Medicine: Promising Areas of Research in Glioma.
    Davis ME; Bossert D; Manne M
    Semin Oncol Nurs; 2018 Dec; 34(5):569-572. PubMed ID: 30409552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.